Clinical trials
Completed Phase 2 Lymphoma, Large-Cell, Anaplastic trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
69 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 7 |
| 2001 | 2 |
| 2002 | 1 |
| 2003 | 4 |
| 2004 | 8 |
| 2005 | 9 |
| 2006 | 1 |
| 2007 | 4 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 5 |
| 2012 | 3 |
| 2013 | 2 |
| 2015 | 2 |
| 2016 | 3 |
| 2018 | 2 |
| 2019 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 69 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 12 |
| Fred Hutchinson Cancer Center | 9 |
| Memorial Sloan Kettering Cancer Center | 4 |
| Case Comprehensive Cancer Center | 3 |
| European Organisation for Research and Treatment of Cancer - EORTC | 3 |
| Mayo Clinic | 3 |
| Seagen Inc. | 3 |
| Children's Cancer Group, China | 2 |
| City of Hope Medical Center | 2 |
| Eastern Cooperative Oncology Group | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Large-Cell, Anaplastic | 69 |
| Lymphoma, Large B-Cell, Diffuse | 47 |
| Lymphoma, Mantle-Cell | 38 |
| Lymphoma, Follicular | 37 |
| Lymphoma, Non-Hodgkin | 37 |
| Burkitt Lymphoma | 36 |
| Lymphoma, Large-Cell, Immunoblastic | 35 |
| Immunoblastic Lymphadenopathy | 33 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 32 |
| Hodgkin Disease | 31 |
Trials
Showing 1 to 25 of 69. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.